Global Dengue Vaccine Market Size (value & volume) by key players, type

Posted by Deeksha on June 17th, 2019

This research report titled “Global Dengue Vaccine Market Insights, Forecast to 2025” has been added to the wide online database managed by Market Research Hub (MRH). The study discusses the prime market growth factors along with future projections expected to impact the Dengue Vaccine Market during the period between 2019 and 2025. The concerned sector is analyzed based on different market factors including drivers, restraints and opportunities in order to enlighten the readers about the actual scenario prevailing in the Dengue Vaccine Market.

Request for sample copy of this report

The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Dengue fever resembles influenza and affects adults, children, as well as infants, but it is rarely fatal. However, dengue hemorrhagic fever is a potentially fatal complication because of multiple factors such as fluid accumulation, severe bleeding, organ impairment, or plasma leaking.
With the increasing population density and global warming, there is a rapid growth in the prevalence of dengue, especially in the tropical and subtropical regions across the world. According to the National Institute of Health, approximately 0.05 to 0.2 billion cases of dengue infections are reported annually and the mortality rate due to dengue was above 20,000. The report has identified the rapid growth in disease incidences as one of the primary factors that will fuel the growth of the dengue vaccine market in the coming years. The prevalence of dengue is present in more than 125 countries across the world and the rising prevalence of dengue will drive the market during the forecast period.
The dengue vaccine market is marginally concentrated due to the presence and dominance of the established players. Several companies are investing in R&D to develop more advanced products and expand their product portfolio. Several organizations are merging for research and making enormous efforts to develop vaccines that can challenge the Sanofi Pasteur's exclusivity in the dengue treatment market. Moreover, several organizations are making huge investments in R&D to develop novel treatment options.
The Americas will be the major revenue contributor to the dengue vaccine market owing to the increasing incidences of dengue cases. The dengue treatment market in the Americas will profit from the bilateral program, Indo-U.S. Vaccine Action Program (VAP), which is concentrated on activities related to immunization and vaccine-related research.
The global Dengue Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dengue Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Dengue Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dengue Vaccine in these regions.
This research report categorizes the global Dengue Vaccine market by top players/brands, region, type and end user. This report also studies the global Dengue Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Merck Sharp & Dohme
Takeda Pharmaceuticals
GeneOne Life Sciences
Medigen Biologics
Panacea Biotec
Sun Pharmaceutical

Market size by Product
DENVax or TAK-003
DNA vaccines
Market size by End User
Government institutions

Market size by Region
North America
United States
South Korea
Central & South America
Rest of Central & South America
Middle East & Africa
GCC Countries
South Africa

Browse Full Report with TOC

Table of Contents

1 Study Coverage
1.1 Dengue Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Dengue Vaccine Market Size Growth Rate by Product
1.4.2 CYD-TDV
1.4.3 DENVax or TAK-003
1.4.4 TetraVax-DV
1.4.6 V180
1.4.7 DNA vaccines
1.5 Market by End User
1.5.1 Global Dengue Vaccine Market Size Growth Rate by End User
1.5.2 Government institutions
1.5.3 Hospitals
1.5.4 NGOs
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Dengue Vaccine Market Size
2.1.1 Global Dengue Vaccine Revenue 2014-2025
2.1.2 Global Dengue Vaccine Sales 2014-2025
2.2 Dengue Vaccine Growth Rate by Regions
2.2.1 Global Dengue Vaccine Sales by Regions
2.2.2 Global Dengue Vaccine Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Dengue Vaccine Sales by Manufacturers
3.1.1 Dengue Vaccine Sales by Manufacturers
3.1.2 Dengue Vaccine Sales Market Share by Manufacturers
3.1.3 Global Dengue Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Dengue Vaccine Revenue by Manufacturers
3.2.1 Dengue Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Dengue Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Dengue Vaccine Price by Manufacturers
3.4 Dengue Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Dengue Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Dengue Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Dengue Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

To be continue@@

Like it? Share it!


About the Author

Joined: January 3rd, 2019
Articles Posted: 12,334

More by this author